查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553597

標靶 DNA RNA定序市場規模、佔有率、趨勢分析報告：按產品、按工作流程、按應用、按技術、按類型、按最終用途、按細分市場預測，2024-2030 年

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

標靶 DNA RNA定序市場成長與趨勢：

預計2030年，全球標靶DNA RNA定序市場規模將達345.6億美元，2024年至2030年複合年成長率為19.4%。

標靶定序已成為生命科學研究中的重要技術，它能夠對感興趣的特定領域進行研究，同時保持定序成本和資料複雜性可控。

這種方法透過允許評估基因內的特定轉錄區或已知持有與疾病發展相關的突變的特定基因來增加定序的深度。一些研究計劃已經採用了這種技術，以避免資訊浪費和額外成本，並僅研究相關基因。此類計劃的數量持續成長，從而推動了市場的發展。

解決定向標靶序列捕獲方法缺陷的技術創新預計將在預測期內提高該技術的使用率。此外，較低的序列成本和改進的資訊學使標靶化方法比以往任何時候都更容易在臨床實踐中使用。

靶向 DNA RNA定序市場報告亮點

  • NGS 及其輔助通訊協定的快速發展正在促進這一領域的成長。
  • 在所有基於NGS的標靶化方法中，EXOME-seq所佔比重最大。
  • 這是因為，雖然它只佔基因組的不到 2%，但它包含 85% 的已知疾病相關變異。
  • 總體標靶方法分為預測定序、序列測定和資料分析。
  • 定序，最重要的一步，佔比最大。
  • 這個領域徹底改變了各種生命科學應用，包括人類生物醫學研究、植物和動物科學以及藥物發現。
  • 其中，人類生物醫學研究估計是該領域最大的應用，因為它經常用於研究疾病的發病機制。
  • 根據樣本類型，目標 DNA/RNA定序市場分為 DNA-seq 和 RNA-seq。
  • 據估計，DNA定序將比相應領域產生更高的收益。這是由於存在多種 DNA 定序產品和試劑套件。
  • 從最終用途來看，由於大學和其他學術中心基於 seq 的計劃的增加，學術研究估計是最大的部分。
  • 由於對基因測試和生物資訊工具的核准存在有效的法規，北美佔據了最大的佔有率。
  • 此外，美國已被證實安裝的定序儀數量最多，佔據了北美地區市場的很大佔有率。
  • 亞太地區預計將成為成長最快的區域市場。
  • 亞洲國家基於基因組的計劃數量的增加和 GDP 的持續成長預計將推動亞太市場的發展。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 標靶 DNA RNA定序序市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 標靶 DNA RNA定序市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 標靶 DNA RNA定序序市場：技術估算與趨勢分析

  • 細分儀表板
  • 標靶 DNA RNA定序市場：2023 年和 2030 年技術變化分析
  • 下一代種子
  • 其他

第5章 標靶 DNA RNA定序市場：依工作流程進行估算與趨勢分析

  • 細分儀表板
  • 標靶 DNA RNA定序市場：工作流程變化分析，2023 年和 2030 年
  • 預測定序
  • 定序
  • 資料分析

第6章 標靶 DNA RNA定序市場：依應用估算與趨勢分析

  • 細分儀表板
  • 標靶 DNA RNA定序市場：2023 年和 2030 年應用變化分析
  • 人類生物醫學研究
  • 植物和動物科學
  • 藥物發現
  • 其他

第7章 靶向 DNA RNA定序市場：按類型估計和趨勢分析

  • 細分儀表板
  • 標靶 DNA RNA定序市場：類型變異分析，2023 年和 2030 年
  • 基於DNA的標靶定序
  • 基於RNA的標靶定序

第 8 章 標靶 DNA RNA定序市場：最終用途的估計與趨勢分析

  • 細分儀表板
  • 標靶 DNA RNA定序市場：最終用途變異分析，2023 年和 2030 年
  • 學術研究
  • 醫院/診所
  • 製藥和生物技術公司
  • 其他

第9章 標靶DNA RNA定序序市場：區域估計與趨勢分析

  • 2023 年及 2030 年按地區分類的標靶 DNA RNA定序市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Illumina
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
簡介目錄
Product Code: GVR-1-68038-681-3

Targeted DNA RNA Sequencing Market Growth & Trends:

The global targeted DNA RNA sequencing market size is expected to reach USD 34.56 billion in 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030. Targeted Sequencing has emerged as a key technology in life science research by enabling examination of a specific region of interest while keeping the seq. cost as well as the complexity of data under manageable limits.

This approach enhances sequencing depth by allowing the evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. The number of such projects continues to grow, consequently driving the market.

Innovations to address the pitfalls of targeted enrichment methods are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with a decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.

Targeted DNA RNA Sequencing Market Report Highlights:

  • Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment.
  • Out of all the NGS-based targeted methods, exome-seq held the largest share.
  • This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants.
  • Entire targeted approach is broken down into presequencing, sequence determination, and data analysis.
  • Being the most crucial step, sequencing accounted for the largest share.
  • This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others.
  • Out of all, human biomedical research is estimated to be the largest application of this space due to its high usage in studying disease pathogenesis.
  • The targeted DNA/RNA sequencing market is bifurcated into DNA-seq and RNA-seq, based on the sample type.
  • DNA-sequencing has been estimated to generate higher revenue over its counterpart segment. This can be attributed to the presence of a wide range of products and kits for DNA-seq.
  • As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers.
  • North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools.
  • Moreover, the U.S. is observed to have the highest number of installed sequencers, which in turn, has contributed to the large share of the North America regional market.
  • Asia Pacific is expected to emerge as the fastest growing regional market.
  • Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Targeted DNA RNA Sequencing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. NGS
    • 4.3.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Method Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.1. Exome Sequencing
        • 4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Enrichment Sequencing
        • 4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Amplicon Sequencing
        • 4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Others
        • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.1. Cancer Gene Sequencing
      • 4.3.3.2. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. Inherited Disease Screening
      • 4.3.3.4. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Drug Development
      • 4.3.3.6. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.7. Forensic Genomics
      • 4.3.3.8. Forensic Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.9. 16S Ribosomal RNA (rRNA)
      • 4.3.3.10. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Pre-sequencing
    • 5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Sequencing
    • 5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Data Analysis
    • 5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Human Biomedical Research
    • 6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Plant & Animal Sciences
    • 6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Drug Discovery
    • 6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. DNA Based Targeted Sequencing
    • 7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. RNA Based Targeted Sequencing
    • 7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 8.3. Academic Research
    • 8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Pharma & Biotech Entities
    • 8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis

  • 9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2023 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. China
      • 9.4.2.1. China Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Japan Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. South Korea Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Australia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Saudi Arabia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. UAE
      • 9.6.3.1. UAE Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. South Africa
      • 9.6.4.1. South Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. Illumina
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Recent Developments/Strategic Initiatives
    • 10.4.2. F. Hoffman-La Roche Ltd.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Recent Developments/Strategic Initiatives
    • 10.4.3. QIAGEN
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Recent Developments/Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Recent Developments/Strategic Initiatives
    • 10.4.5. Bio-Rad Laboratories, Inc.
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Oxford Nanopore Technologies
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Recent Developments/Strategic Initiatives
    • 10.4.7. PierianDx
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Recent Developments/Strategic Initiatives
    • 10.4.8. Genomatix GmbH
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Recent Developments/Strategic Initiatives
    • 10.4.9. DNASTAR, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Recent Developments/Strategic Initiatives
    • 10.4.10. Perkin Elmer, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Recent Developments/Strategic Initiatives